Clinical trial
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia…
NCT00211380 · Louisiana State University Health Sciences Center Shreveport, Other · Terminated
Key facts
| NCT number | NCT00211380 |
|---|---|
| Title | Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) |
| Official title | Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia, (SFBRI). |
| Lead sponsor | Louisiana State University Health Sciences Center Shreveport, Other |
| Collaborators | SAM Technology & The San Francisco Brain Research Institute |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | aripiprazole |
| Enrollment | 8 |
| Start date | Aug 1, 2003 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: